ReviewPharmacoEconomics2013
Ruxolitinib for the treatment of myelofibrosis: a NICE single technology appraisal.
Ros Wade et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ReviewPharmacoEconomics2013
Ros Wade et al.PubMed ↗Publisher ↗
No numbers read from the abstract.